申请人:MERRELL DOW PHARMACEUTICALS INC.
公开号:EP0146067A2
公开(公告)日:1985-06-26
This invention relates to substrates of D-amino acid oxidase which are valuable therapeutic agents. More particularly, the compounds of the present invention includes a D-amino acid oxidase substrate of the structural formula
and the pharmaceutically acceptable salts thereof, wherein R is H, -CH3, -CH3CH2-, CH3CH2CH2-, CH3(CH2)2CH2-, (CH3) 2CH-,
-CH20H, CH3CH2SCH2CH2-, CH3SCH2-, CH3SCH2CH2-, C6H5CH2-, 4-OH-C6H4 CH2-, 3,4-diOH-C6H3CH2- and
and R1 is the des-amino residue of a -NH2 bearing therapeutic agent.
本发明涉及作为有价值的治疗剂的 D-氨基酸氧化酶底物。更具体地说,本发明的化合物包括结构式如下的 D-氨基酸氧化酶底物及其药学上可接受的盐类
及其药学上可接受的盐,其中 R 是 H、-CH3、-CH3CH2-、CH3CH2CH2-、CH3(CH2)2CH2-、(CH3) 2CH-、
-CH20H、CH3CH2SCH2CH2-、CH3SCH2-、CH3SCH2CH2-、C6H5CH2-、4-OH-C6H4 CH2-、3,4-diOH-C6H3CH2-和
和 R1 是含有-NH2 的治疗剂的去氨基残基。